Vivostat’s Technology Turns Blood Into Surgical Glue
Vivostat is a Danish company that uses the patient’s blood to create a personalized surgical glue (fibrin sealant) that can be used for surgical procedures and the treatment of diabetic ulcers.
Profiles
Chembio Diagnostics Tackles Infectious Diseases with Rapid-Diagnostic Platform
Chembio Diagnostics specializes in the development of advanced diagnostic tests for infectious diseases such as HIV and syphilis.
Oculus Looks Beyond Wound Care Market
Petaluma, Calif.-based Oculus Innovative Sciences specializes in the development of products to treat and prevent infections in wounds.
Urovalve at the 2010 OneMedForum
Harvey Homan, President and CEO of Urovalve, discusses his company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
The Universal Vaccines of Inovio Biomedical
Inovio is developing a universal flu vaccine engineered to prevent several strains of influenza at once.
Cantimer’s Portable Devices Keep It Simple
The company’s key product is a portable hydration monitor that can gauge an individual’s level of hydration from a drop of saliva in approximately one minute.
SEA Medical Systems at the 2010 OneMedForum
Michael Weickert, President and CEO of SEA Medical Systems, Inc., discusses his company with OneMedTV correspondent Alicia Ontiveros at the 2010 OneMedForum in San Francisco.
TapImmune Taps Into Cancer Defense
How do cancer cells evade the immune system, growing undetected until they’re discovered as a tumor?
Generex Biotechnology at the 2010 OneMedForum
Anna Gluskin, President and CEO of Generex Biotechnology, discusses her company with William Dawson of LifeTech Capital at the 2010 OneMedForum in San Francisco.
OraMed Pharmaceuticals and Its Oral Insulin Pill
Oramed Pharmaceuticals in Jerusalem is developing a product that could potentially revolutionize the way diabetes is treated.